nccn-non-small-cell-lung-cancer

name	nccn-non-small-cell-lung-cancer
description	NCCN clinical practice guideline navigation for Non-Small Cell Lung Cancer. Use when a clinician needs treatment decisions, staging, workup, or evidence for Non-Small Cell Lung Cancer based on NCCN Guidelines version 3.2026.
metadata	{"author":"nccn-skill-generator","version":"3.2026","source":"NCCN Clinical Practice Guidelines in Oncology","guideline":"Non-Small Cell Lung Cancer"}
license	See NCCN terms of use

NCCN Guidelines: Non-Small Cell Lung Cancer

Clinical decision support derived from NCCN Clinical Practice Guidelines in Oncology. Version 3.2026.

Disease Subtypes

Prevention and Screening

• Algorithm: Prevention and Screening -- Staging, workup, and treatment pathways

Presentation and Risk Assessment

• Algorithm: Presentation and Risk Assessment -- Staging, workup, and treatment pathways

Surveillance

• Algorithm: Surveillance -- Staging, workup, and treatment pathways
• Evidence: Surveillance -- Discussion of clinical evidence and rationale

Recurrence and Metastasis

• Algorithm: Recurrence and Metastasis -- Staging, workup, and treatment pathways

Advanced or Mestastatic Disease

• Algorithm: Advanced or Mestastatic Disease -- Staging, workup, and treatment pathways

Neoadjuvant/Adjuvant Therapy Regimens

• Algorithm: Neoadjuvant/Adjuvant Therapy Regimens -- Staging, workup, and treatment pathways

Chemotherapy with RT regimens

• Algorithm: Chemotherapy with RT regimens -- Staging, workup, and treatment pathways

Systemic Therapy Regimens and References

• Algorithm: Systemic Therapy Regimens and References -- Staging, workup, and treatment pathways

Literature Search Criteria

• Evidence: Literature Search Criteria -- Discussion of clinical evidence and rationale

Risk Factors

• Evidence: Risk Factors -- Discussion of clinical evidence and rationale

Smoking Cessation

• Evidence: Smoking Cessation -- Discussion of clinical evidence and rationale

Lung Cancer Screening

• Evidence: Lung Cancer Screening -- Discussion of clinical evidence and rationale

Classification and Prognostic Factors

• Evidence: Classification and Prognostic Factors -- Discussion of clinical evidence and rationale

Diagnostic Evaluation

• Evidence: Diagnostic Evaluation -- Discussion of clinical evidence and rationale

Pathologic Evaluation of Lung Cancer

• Evidence: Pathologic Evaluation of Lung Cancer -- Discussion of clinical evidence and rationale

Treatment Approaches

• Evidence: Treatment Approaches -- Discussion of clinical evidence and rationale

Clinical Evaluation

• Evidence: Clinical Evaluation -- Discussion of clinical evidence and rationale

Initial Therapy

• Evidence: Initial Therapy -- Discussion of clinical evidence and rationale

Neoadjuvant or Adjuvant Therapy

• Evidence: Neoadjuvant or Adjuvant Therapy -- Discussion of clinical evidence and rationale

Treatment of Recurrences and Distant Metastases

• Evidence: Treatment of Recurrences and Distant Metastases -- Discussion of clinical evidence and rationale

Systemic Therapy for Advanced or Metastatic NSCLC: Other Options

• Evidence: Systemic Therapy for Advanced or Metastatic NSCLC: Other Options -- Discussion of clinical evidence and rationale

Summary

• Evidence: Summary -- Discussion of clinical evidence and rationale

Shared Resources

Initial Evaluation and Treatment

• Initial Evaluation and Treatment -- Shared clinical resource

Principles of Pathologic Review

• Principles of Pathologic Review -- General treatment principles

Principles of Surgical Therapy

• Principles of Surgical Therapy -- Surgical treatment principles

Principles of Radiation Therapy

• Principles of Radiation Therapy -- Radiation therapy guidelines

Survivorship Care

• Survivorship Care -- Survivorship care guidelines

Principles of Molecular/Biomarker Analysis

• Principles of Molecular/Biomarker Analysis -- General treatment principles

Emerging Biomarkers

• Emerging Biomarkers -- Biomarker testing guidelines

Overview

• Overview -- Shared clinical resource

Guidelines Update Methodology

• Guidelines Update Methodology (Evidence) -- Shared clinical resource

Sensitive/Inclusive Language Usage

• Sensitive/Inclusive Language Usage (Evidence) -- Shared clinical resource

Staging

• Staging (Evidence) -- Staging classification

Predictive and Prognostic Biomarkers

• Predictive and Prognostic Biomarkers (Evidence) -- Biomarker testing guidelines

Systemic Therapy for Advanced or Metastatic NSCLC with Actionable Biomarkers

• Systemic Therapy for Advanced or Metastatic NSCLC with Actionable Biomarkers (Evidence) -- Biomarker testing guidelines

---

Citation: NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer, Version 3.2026. National Comprehensive Cancer Network. Available at nccn.org.

This skill references copyrighted NCCN content. Refer to nccn.org for the authoritative source and full terms of use.